SCHEMBL31219977

SCHEMBL31219977

CC1(C)OB(c2ccc3c(cnn3COCC[Si](C)(C)C)c2Cl)OC1(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24343810 0.88 UCHL1 (0.35) UCHL1
SCHEMBL25347436 0.86 UCHL1 (0.36) UCHL1
SCHEMBL30976712 0.84 UCHL1 (0.34) UCHL1
SCHEMBL30311885 0.83 UCHL1 (0.35) UCHL1
SCHEMBL31104175 0.79 UCHL1 (0.37) UCHL1
SCHEMBL19626235 0.79 UCHL1 (0.39) UCHL1
SCHEMBL26695189 0.79 UCHL1 (0.30) UCHL1
SCHEMBL31083110 0.78 UCHL1 (0.32) UCHL1
SCHEMBL31219974 0.78 DGAT1 (0.34) —
SCHEMBL29514366 0.77 UCHL1 (0.33) UCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713096-A1 CDK INHIBITOR COMPOUNDS Aleksia Therapeutics, Inc. (US) 2026-03-25 — — EP disclosed
WO-2024238574-A1 CDK INHIBITOR COMPOUNDS ALEKSIA THERAPEUTICS, INC. (US) 2024-11-21 — — WO disclosed
Send feedback